Search results
- 1.7600Add to watchlist+0.0400 (+2.33%)At close: Fri. Apr 26, 2024 3:59 PM EDT · Delayed Quote (USD) · Market closed
- Open1.7700High1.8000Low1.7236
- Mkt Cap15.16MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.720052 Wk. Low1.020052 Wk. High22.8000
Related stocks
1.7200 0.00 (0.00%) After hours: 6:09 PM EDT. Mountain. Loading Chart for IBIO. 9/21 12:03 PM. Previous Close 1.9000. Open 1.8700. Bid 1.6900 x 1300. Ask 1.7400 x 1200. Day's Range 1.6800 -...
- Conversations
Find the latest iBio, Inc. (IBIO) stock discussion in Yahoo...
- Analysis
See iBio, Inc. (IBIO) stock analyst estimates, including...
- Statistics
Find out all the key statistics for iBio, Inc. (IBIO),...
- Profile
See the company profile for iBio, Inc. (IBIO) including...
- Options
View the basic IBIO option chain and compare options of...
- Press Releases
iBio Announces Reverse Stock Split. BRYAN, Texas and SAN...
- Conversations
Apr 19, 2024 · IBIO | Complete iBio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Get the latest Ibio Inc (IBIO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
A high-level overview of iBio, Inc. (IBIO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
People also ask
Where is IBio Inc headquartered?
Where can I buy IBio (IBio) stock?
Does NASDAQ use IBio (IBio) stock value to determine compliance?
How much does IBio (IBio) cost?
IBIO. +3.49%. Get the latest iBio, Inc. (IBIO) stock news and headlines to help you in your trading and investing decisions.
- 0.0000 x 800
- 2.1200
- 0.0000 x 1100
- 2.1100
iBio, Inc. Common Stock (IBIO) 0. Add to Watchlist. Add to Portfolio. Summary. Real-Time. After-Hours. Pre-Market. Charts. Live. PreviousClose. Key Data. Label. Value. See More. Bid Price and...
Apr 17, 2024 · Get the latest information on iBio, Inc. (IBIO), a biotechnology company that develops precision antibody immunotherapies using AI. See stock performance, financials, news, analysis, and more.